$64.3 million state-of-the-art facility has been performing laboratory services since Aug. 23

FOR IMMEDIATE RELEASE:

DANVILLE, PA -- Conrad Schuerch, M.D, has waited 34 years for a new laboratory. Geisinger’s chairman of laboratory medicine will now tell you that the new $64.3 million state-of-the-art facility at Geisinger Medical Center has been worth the wait.

The laboratory medicine staff has been conducting all inpatient laboratory services from their new 162,000 square foot Laboratory Medicine Building since Aug. 23. The building was officially christened during a morning ribbon-cutting ceremony on Sept. 24.

The building features four laboratory medicine levels, with a lower level devoted to Geisinger’s food service department. It provides space for programmatic growth, expanding Geisinger laboratory medicine’s clinical, research and teaching programs. And it’s conveniently located by GMC’s Hospital for Advanced Medicine (HfAM) and parking garage, with connections to both.

It replaces the interim lab building, which was built in 1984.

“I think we have actually achieved the ideal in terms of efficiency,” Dr. Schuerch said. “This is something that’s been needed for a very long time.”

Ground was broken on the Laboratory Medicine Building on March 21, 2013. It provides enhanced laboratory testing, education and research areas, as well as staff and employee offices, meeting rooms and support areas.

While a pneumatic tube system was already sending medical materials throughout GMC, the one installed in the new building uses “Smart Path” technology to greatly reduce turnaround time for delivering specimens to other parts of the lab.

The building also features Remstar storage units, which extend up to 40 feet vertically from floor to floor through unused ceiling space. These units provide centralized storage for specimens, reagents, supplies, surgical blocks and slides at a diminished cost of equivalent linear space. The model provides highly efficient access for all necessary supplies to enhance workflows.

The facility also provides space to expand laboratory medicine’s teaching capacity to accommodate a future pathology residency program, a larger cytopathology fellowship program, and – eventually – a transfusion medicine fellowship program.

“Abigail Geisinger challenged us all to ‘Make it the best,’ and I think this new building is an example of how we’re doing just that in laboratory medicine,” said Geisinger President and CEO David T. Feinberg, who spoke at the grand opening. “While this is truly one of the world’s finest laboratory facilities and expands upon our food service capabilities, the most important thing is that it allows us to better serve our patients and improve upon their care.” 

 

About Geisinger
Geisinger is an integrated health services organization widely recognized for its innovative use of the electronic health record and the development of innovative care delivery models such as ProvenHealth Navigator®, ProvenCare® and ProvenExperience®. As one of the nation’s largest health service organizations, Geisinger serves more than 3 million residents throughout 45 counties in central, south-central and northeast Pennsylvania, and also in southern New Jersey at AtlantiCare, a Malcolm Baldrige National Quality Award recipient. In 2017, the Geisinger Commonwealth School of Medicine and Geisinger Jersey Shore Hospital became the newest members of the Geisinger Family. The physician-led system is comprised of approximately 30,000 employees, including nearly 1,600 employed physicians, 13 hospital campuses, two research centers, and a 583,000-member health plan, all of which leverage an estimated $12.7 billion positive impact on the Pennsylvania and New Jersey economies. Geisinger has repeatedly garnered national accolades for integration, quality and service. In addition to fulfilling its patient care mission, Geisinger has a long-standing commitment to medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.

For media inquiries:

Corporate Communications
570-808-5813